|Prethrombotic state due to hypercoagulability in patients with permanent transvenous pacemakers.|
|PMID: 9342969 Owner: NLM Status: MEDLINE|
|Venous thrombosis is a relatively usual but serious complication of permanent transvenous pacing. However, the pathogenesis has not been defined. To clarify underlying abnormalities in the coagulation-fibrinolysis system in patients with permanent transvenous pacemakers, we measured serum levels of fibrinopeptide A (FPA), thrombin-antithrombin III complexes (TATs), plasmin-alpha 2 plasmin inhibitor complexes (PICs), D-dimer (D-D), beta-thromboglobulin (beta-TG), and platelet factor 4 (PF4) in 53 patients with permanent transvenous pacemakers and 10 control subjects. The patients were divided into two groups, as follows, according to the presence of mural thrombus documented along the pacing lead(s) by digital subtraction angiography and transesophageal echocardiography: Group Th (-), patients without venous route thrombus; and Group Th (+), patients with venous route thrombus. FPA and TAT levels increased significantly even in Group Th (-), and further increased in Group Th (+) compared with control subjects (FPA: 7.5 +/- 4.9, 15.3 +/- 8.8 vs 3.0 +/- 1.4 ng/mL, respectively, P < 0.05; TAT: 2.9 +/- 1.3, 4.8 +/- 2.3 vs 1.7 +/- 0.6 ng/mL, respectively, P < 0.05). There were no differences in levels of D-D, PIG, beta-TG, and PF4 among control subjects, Group Th (-), and Group Th (+). These findings suggest that the hypercoagulable state appears in patients with permanent transvenous pacemakers, even without apparent venous thrombosis. The patients with permanent transvenous pacemakers are thought to be in the prethrombotic state even if they have no venous route thrombosis.|
|T Ito; J Tanouchi; J Kato; M Nishino; K Iwai; H Tanahashi; M Hori; Y Yamada; T Kamada|
Related Documents :
|8322149 - Placement of central venous catheters by cut-down with electrocardiogram positioning.
17579309 - The use of knee-length versus thigh-length compression stockings and sequential compres...
15049719 - Should thrombolytic therapy be used in patients with pulmonary embolism?
18282149 - The paradoxical association between inherited factor vii deficiency and venous thrombosis.
18159459 - Predictors of a positive duplex scan in patients with a clinical presentation compatibl...
11174739 - Heparin antibodies and thromboembolism in heparin-coated and noncoated ventricular assi...
18790339 - Hypoxemia-orthodeoxia related to patent foramen ovale without pulmonary hypertension.
8874069 - Sinusitis in mechanically ventilated patients and its role in the pathogenesis of nosoc...
2267279 - Renovascular disease and renal complications of angiotensin-converting enzyme inhibitor...
|Type: Comparative Study; Journal Article|
|Title: Angiology Volume: 48 ISSN: 0003-3197 ISO Abbreviation: Angiology Publication Date: 1997 Oct|
|Created Date: 1997-11-18 Completed Date: 1997-11-18 Revised Date: 2009-11-19|
Medline Journal Info:
|Nlm Unique ID: 0203706 Medline TA: Angiology Country: UNITED STATES|
|Languages: eng Pagination: 901-6 Citation Subset: IM|
|Division of Cardiology, Osaka Rosai Hospital, Japan.|
|APA/MLA Format Download EndNote Download BibTex|
Aged, 80 and over
Angiography, Digital Subtraction
Antifibrinolytic Agents / blood
Antithrombin III / analysis
Blood Coagulation / physiology*
Cardiac Pacing, Artificial / adverse effects
Fibrin Fibrinogen Degradation Products / analysis
Fibrinolysin / analysis
Fibrinolysis / physiology
Fibrinolytic Agents / blood
Fibrinopeptide A / analysis
Heart Diseases / blood, etiology, radiography, ultrasonography
Pacemaker, Artificial / adverse effects*
Peptide Hydrolases / analysis
Platelet Factor 4 / analysis
Serine Proteinase Inhibitors / blood
Thrombophlebitis / blood, etiology
Thrombosis / blood, etiology*, radiography, ultrasonography
alpha-2-Antiplasmin / analysis
beta-Thromboglobulin / analysis
|0/Antifibrinolytic Agents; 0/Fibrin Fibrinogen Degradation Products; 0/Fibrinolytic Agents; 0/Serine Proteinase Inhibitors; 0/alpha-2-Antiplasmin; 0/antithrombin III-protease complex; 0/beta-Thromboglobulin; 0/fibrin fragment D; 25422-31-5/Fibrinopeptide A; 37270-94-3/Platelet Factor 4; 9000-94-6/Antithrombin III; EC 3.4.-/Peptide Hydrolases; EC 18.104.22.168/Fibrinolysin|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Relationship between ultrasound assessment of arterial wall properties and blood pressure.
Next Document: New stenosis on proximal coronary segment after directional atherectomy. Two case reports.